Biobehavioral and psychosocial stress changes during three 8-12 month spaceflight analog missions with Mars-like conditions of isolation and confinement.
activity
confinement
cortisol
dopamine
isolation
serotonin
sleep
stress
Journal
Frontiers in physiology
ISSN: 1664-042X
Titre abrégé: Front Physiol
Pays: Switzerland
ID NLM: 101549006
Informations de publication
Date de publication:
2022
2022
Historique:
received:
18
03
2022
accepted:
07
11
2022
entrez:
26
12
2022
pubmed:
27
12
2022
medline:
27
12
2022
Statut:
epublish
Résumé
Prior theories about individual and team adaptation to living and working in an isolated and confined environment (ICE) have been derived from the experiences of individuals who winter-over in Antarctica or deploy for long durations in submarines. These theories are typically described as a 3- to 4-stage process with phases of excitement and elevated alertness, then followed by difficult phases, including depression and volatility. To further evaluate the applicability of these theories to long-duration human spaceflight missions, longitudinal stress responses to prolonged isolation and confinement of three 6-person crews during 8-12 months simulated Mars missions were characterized through metabolite profiling (biomarkers in hair and urine samples), wearables monitoring (sleep and activity levels), and self-reported ratings of stress, mood, social participation, and perceived health. These data were normalized, aggregated, and clustered to analyze longitudinal trends in biobehavioral and psychosocial stress measures. As a result, this analysis presents a theoretical model that triangulates aspects of prior theories with new evidence to describe ICE stress at HI-SEAS as 1) eustress of initial adaptation (high stress hormone levels at mission start), 2) deprivation due to prolonged isolation and confinement (decreasing dopamine and serotonin levels), 3) disruption of individual and team dynamics (changes in activity levels, mood, perceived stress, and social participation) and 4) asynchronous coping (changes in sleep-wake cycles, outlook, and team cohesion). These findings support several aspects of prior theories in combination, such as the elevated alertness at mission start and that adverse conditions are most likely to develop after the halfway point of a mission (e.g. for HI-SEAS 8-12 months missions, after approximately 6 months) followed by a period of volatility until the end (e.g. as stated in Rohrer's theory, ups and downs until the end, not a renewed outlook at the end as described in 3rd quarter phenomenon theory).
Identifiants
pubmed: 36569765
doi: 10.3389/fphys.2022.898841
pii: 898841
pmc: PMC9768546
doi:
Types de publication
Journal Article
Langues
eng
Pagination
898841Informations de copyright
Copyright © 2022 Dunn Rosenberg, Jannasch, Binsted and Landry.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Schizophr Res. 2012 May;137(1-3):73-9
pubmed: 22353995
Nat Rev Neurosci. 2009 Jun;10(6):410-22
pubmed: 19455173
PLoS One. 2014 Mar 27;9(3):e93298
pubmed: 24675720
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Oct 1;1002:92-7
pubmed: 26319301
Cogn Affect Behav Neurosci. 2001 Dec;1(4):388-93
pubmed: 12467090
J Neuroinflammation. 2022 Feb 2;19(1):33
pubmed: 35109857
Curr Opin Neurobiol. 2004 Apr;14(2):198-202
pubmed: 15082325
Life Sci. 1985 Feb 18;36(7):671-7
pubmed: 3918227
Healthcare (Basel). 2017 Nov 18;5(4):
pubmed: 29156540
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Jun 1;928:1-8
pubmed: 23584040
Front Physiol. 2015 Aug 19;6:230
pubmed: 26347657
Perspect Biol Med. 2018;61(4):472-488
pubmed: 30613031
Biol Psychiatry. 2003 Aug 1;54(3):200-7
pubmed: 12893096
Metabolism. 2005 May;54(5 Suppl 1):20-3
pubmed: 15877308
Mol Med. 2003 May-Aug;9(5-8):125-34
pubmed: 14571320
Physiol Behav. 2012 Apr 12;106(1):29-39
pubmed: 21888923
Am J Physiol. 1984 Aug;247(2 Pt 1):E157-65
pubmed: 6380304
Stress Health. 2015 Dec;31(5):403-10
pubmed: 24616284
Nat Neurosci. 2002 Nov;5(11):1242-7
pubmed: 12379862
Ann N Y Acad Sci. 2006 Jul;1071:67-79
pubmed: 16891563
Int J Biol Sci. 2008 Apr 29;4(3):126-32
pubmed: 18449357